To systematically examine the effects of dopaminergic agents (modafinil, armodafinil, pramipexole, methylphenidate, and amphetamines) on bipolar depression outcomes. Login using your SSSFT NHS OpenAthens for full text. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
The aim of our study was to investigate, in bipolar patients, whether affect lability was associated with suicidal ideation incidence during 2-year follow-up, and which subtype of affect lability was associated with suicidal ideation. Login using your SSSFT NHS OpenAthens for full text. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
To examine the level of agreement across professionally auspiced evidence-based guidelines for managing the bipolar disorders. Login using your SSSFT NHS OpenAthens for full text. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Clinical trials have examined the efficacy of drugs to prevent relapse in patients with bipolar disorder, however, their design often limits generalisation to routine clinical practice. You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Although there are consistent reports of higher psychosis rates among immigrants, the information on mood disorders is limited. You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Baclofen-Related Mania: Lower Threshold for Bipolar Patients? SSSFT staff can use the OVID link, or you can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Affective Recurrences in Bipolar Disorder After Switching From Lithium to Valproate or Vice Versa: A Series of 57 Cases. SSSFT staff can use the OVID link, or you can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Long-Acting Aripiprazole in Comorbid Bipolar Disorder and Borderline Personality Disorder and Substance Abuse. SSSFT staff can use the OVID link, or you can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Memantine as an Adjuvant Treatment for Obsessive Compulsive Symptoms in Manic Phase of Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. SSSFT staff can use the OVID link, or you can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Lymphocyte Phospho-Ser-9-GSK-3/Total GSK-3 Protein Levels Ratio Is Not Affected by Chronic Lithium or Valproate Treatment in Euthymic Patients With Bipolar Disorder. SSSFT staff can use the OVID link, or you can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Bipolar disorder is a common mental disorder that can be challenging to diagnose. This brief article outlines how bipolar disorder is diagnosed and how it can be distinguished from other disorders with similar phenotypes. Login using your SSSFT NHS OpenAthens for full text. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Mary Lou Chatterton, Emily Stockings, Michael Berk, Jan J. Barendregt, Rob Carter and Cathrine Mihalopoulos have entered published data identified by systematic review from psychosocial interventions for bipolar disorder into a network meta-analysis (Chatterton et al, 2017) focused on:
Relapse to mania or depression,
Medication adherence, and
Symptom scales for mania, depression and Global Assessment of Functioning (GAF).
Cognitive impairment is present in euthymic patients with bipolar disorder and correlates with impairments in everyday functioning. We aimed to examine the efficacy of lurasidone adjunctive therapy compared with treatment as usual (TAU) in improving cognition. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
Comment. Cognitive deficits such as problems with attention, executive functioning, and working memory are a major driver of functional impairment and ensuing disability, with impacts across the spectrum of major neuropsychiatric disorders. For example, cognition is recognised in schizophrenia as one of the principal symptomatic domains.1 The study by Lakshmi N Yatham and colleagues2 in this issue of The Lancet Psychiatry suggesting the utility of lurasidone to improve cognition in bipolar disorder is a welcome contribution to the evidence base in this neglected area. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
Letter. : Login at top right hand side of page using your SSSFT NHS Athens for full text. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Letter. : Login at top right hand side of page using your SSSFT NHS Athens for full text. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
To examine emotion processing in euthymic bipolar patients (EBP) compared to healthy controls. In addition, to determine whether or not there is an association between emotion processing and psychosocial functioning. Login using your SSSFT NHS OpenAthens for full text. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
To identify risk factors for suicide attempts (SA) in individuals commencing treatment for a manic or mixed episode. Login using your SSSFT NHS OpenAthens for full text. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
The authors compared medication-induced mood switch risk (primary outcome), as well as treatment response and side effects (secondary outcomes) with three acute-phase treatments for bipolar II depression. Login at top right hand side of page using your SSSFT NHS Athens for full text. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.